Related Experiment Videos
Moral assessment of growth hormone therapy for children with idiopathic short stature
1Catholic University, Nijmegen.
Insights
Growth hormone therapy for idiopathic short stature in children raises ethical questions. The focus should be on preventing psychosocial issues, not just enhancing height, for medical treatment and research.
Area of Science:
- Pediatric Endocrinology
- Medical Ethics
- Philosophy of Medicine
Background:
- Controversy surrounds growth hormone (GH) therapy for children without GH deficiency.
- Idiopathic short stature (ISS) presents medical, moral, and philosophical challenges.
- Evaluating GH treatment requires a normative perspective beyond clinical data.
Purpose of the Study:
- To examine human growth hormone (hGH) treatment for ISS from ethical viewpoints.
- To analyze the implications of hGH therapy for children with ISS.
- To establish a framework for evaluating the appropriateness of hGH treatment.
Main Methods:
- Normative ethical analysis.
- Consideration of medical goals.
- Evaluation from the patient's and public's good.
Main Results:
- hGH treatment for ISS is ethically complex.
- Data alone is insufficient for decision-making.
- Ethical evaluation must consider broader societal and patient well-being.
Conclusions:
- The primary goal of medical intervention for ISS should be mitigating psychological and social problems.
- Enhancement of growth alone is not a sufficient justification for hGH therapy.
- Future research and treatment should prioritize psychosocial outcomes.
Abstract:
The prescription of growth hormone therapy for children who are not growth hormone deficient is one of the controversies in contemporary paediatric endocrinology. Is it morally appropriate to enhance the growth, by means of medical treatment, of a child wish idiopathic short stature? The medical, moral, and philosophical questions in this area are many. Data on the effects of human growth hormone (hGH) treatment will not on their own provide us with answers, as these effects have to be evaluated from a normative perspective. In this article we consider hGH treatment for children of idiopathic short stature from three normative perspectives: the goals of medicine, the good of the patient, and the public good. We argue that the prevention of psychological and social problems due to short stature (and not merely the enhancement of growth) should be the ultimate goal of medical treatment and research.